American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 683-690 , October 2008

Risk Factors for Proteinuria in HIV-Infected and -Uninfected Hispanic Drug Users

  • Martin S. Rhee, MD

      Affiliations

    • Department of Medicine, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Martin S. Rhee, MD, Tufts Medical Center, 800 Washington St, Box 41, Boston, MA 02111
  • ,
  • Christopher H. Schmid, PhD

      Affiliations

    • Biostatistics Research Center, Tufts Medical Center, Boston, MA
  • ,
  • Lesley A. Stevens, MD, MS

      Affiliations

    • Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA
  • ,
  • Janet E. Forrester, PhD

      Affiliations

    • Department of Public Health and Family Medicine, Tufts University School of Medicine, Boston, MA

Received 13 September 2007 ,Accepted 14 April 2008.

References 

  1. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559–1585
  2. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS. 2004;18:541–546
  3. Bruggeman LA, Ross MD, Tanji N, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol. 2000;11:2079–2087
  4. Marras D, Bruggeman LA, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002;8:522–526
  5. Green DF, Resnick L, Bourgoignie JJ. HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int. 1992;41:956–960
  6. Rao TK, Nicastri AD, Friedman EA. Natural history of heroin-associated nephropathy. N Engl J Med. 1974;290:19–23
  7. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465–470
  8. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease (The Modification of Diet in Renal Disease Study). Ann Intern Med. 1995;123:754–762
  9. Grimm RH, Svendsen KH, Kasiske B, Keane WF, Wahi MM. Proteinuria is a risk factor for mortality over 10 years of follow-up (MRFIT Research Group. Multiple Risk Factor Intervention Trial). Kidney Int Suppl. 1997;63:S10–S14
  10. Wagner DK, Harris T, Madans JH. Proteinuria as a biomarker: Risk of subsequent morbidity and mortality. Environ Res. 1994;66:160–172
  11. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782
  12. Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dube MP. Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol. 2004;61:1–6
  13. Szczech LA, Hoover DR, Feldman JG, et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis. 2004;39:1199–1206
  14. Forrester JE, Tucker KL, Gorbach SL. Dietary intake and body mass index in HIV-positive and HIV-negative drug abusers of Hispanic ethnicity. Public Health Nutr. 2004;7:863–870
  15. Choudhry S, Coyle NE, Tang H, et al. Population stratification confounds genetic association studies among Latinos. Hum Genet. 2006;118:652–664
  16. Levey AS, Greene T, Kusek JW, Beck GJ. MDRD Study Group: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A;(abstr)
  17. Katz A, Nambi SS, Mather K, et al. Quantitative Insulin Sensitivity Check Index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410
  18. Gardner LI, Holmberg SD, Williamson JM, et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003;32:203–209
  19. Szczech LA, Grunfeld C, Scherzer R, et al. Microalbuminuria in HIV infection. AIDS. 2007;21:1003–1009
  20. McGinn JT, McGinn TG, Cherubin CE, Hoffman RS. Nephrotic syndrome in drug addicts. N Y State J Med. 1974;74:92–95
  21. Kilcoyne MM, Gocke DJ, Meltzer JI, et al. Nephrotic syndrome in heroin addicts. Lancet. 1972;1:17–20
  22. Eknoyan G, Gyorkey F, Dichoso C, et al. Renal involvement in drug abuse. Arch Intern Med. 1973;132:801–806
  23. Dettmeyer RB, Preuss J, Wollersen H, Madea B. Heroin-associated nephropathy. Expert Opin Drug Saf. 2005;4:19–28
  24. Bakir AA, Dunea G. Drugs of abuse and renal disease. Curr Opin Nephrol Hypertens. 1996;5:122–126
  25. Friedman EA, Tao TK. Disappearance of uremia due to heroin-associated nephropathy. Am J Kidney Dis. 1995;25:689–693
  26. Szczech LA, Gange SJ, van der HC, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61:195–202
  27. Huang JF, Chuang WL, Dai CY, et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: Another chain of link?. J Intern Med. 2006;260:255–262
  28. Liangpunsakul S, Chalasani N. Relationship between hepatitis C and microalbuminuria: Results from the NHANES III. Kidney Int. 2005;67:285–290
  29. Muramatsu T, Hora K, Ako S, Tachibana N, Hora K, Tanaka E. The role of hepatitis C virus infection in glomerulopathy. Hepatol Res. 2000;18:190–202
  30. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM. Relationship between hepatitis C and chronic kidney disease: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2006;17:1168–1174
  31. Frassetto L, Schoenfeld PY, Humphreys MH. Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital. Am J Kidney Dis. 1991;18:655–659
  32. Shahinian V, Rajaraman S, Borucki M, Grady J, Hollander WM, Ahuja TS. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis. 2000;35:884–888
  33. Carbone L, D'Agati V, Cheng JT, Appel GB. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med. 1989;87:389–395
  34. National Institutes of Health: Strategic Development and Planning Meeting Baseline Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney; 2001;
  35. US Renal Data System. USRDS 2001 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney; 2001;

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Robert Nelson, MD, National Institutes of Health) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

 Originally published online as doi:10.1053/j.ajkd.2008.04.0161 on June 20, 2008.

PII: S0272-6386(08)00831-7

doi: 10.1053/j.ajkd.2008.04.016

American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 683-690 , October 2008